133 related articles for article (PubMed ID: 3355601)
21. Human mitochondrial thymidine kinase is selectively inhibited by 3'-thiourea derivatives of beta-thymidine: identification of residues crucial for both inhibition and catalytic activity.
Balzarini J; Van Daele I; Negri A; Solaroli N; Karlsson A; Liekens S; Gago F; Van Calenbergh S
Mol Pharmacol; 2009 May; 75(5):1127-36. PubMed ID: 19233899
[TBL] [Abstract][Full Text] [Related]
22. In vivo modulation of iododeoxyuridine metabolism and incorporation into cellular DNA by 5'-amino-5'-deoxythymidine in normal mouse tissues and two human colon cancer xenografts.
Kinsella TJ; Glennon MC; Kunugi KA; Lindstrom MJ
Clin Cancer Res; 1996 Jun; 2(6):981-9. PubMed ID: 9816259
[TBL] [Abstract][Full Text] [Related]
23. 3'-Azido-3'-deoxythymidine cytotoxicity and metabolism in the human colon tumor cell line HCT-8.
Darnowski JW; Goulette FA
Biochem Pharmacol; 1994 Nov; 48(9):1797-805. PubMed ID: 7980649
[TBL] [Abstract][Full Text] [Related]
24. The kinetic effects on thymidine kinase 2 by enzyme-bound dTTP may explain the mitochondrial side effects of antiviral thymidine analogs.
Wang L; Sun R; Eriksson S
Antimicrob Agents Chemother; 2011 Jun; 55(6):2552-8. PubMed ID: 21444706
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of vaccinia virus thymidine kinase by the distal products of its own metabolic pathway.
Hruby DE
Virus Res; 1985 Mar; 2(2):151-6. PubMed ID: 3993232
[TBL] [Abstract][Full Text] [Related]
26. 2'-O-Acyl/alkyl-substituted arabinosyl nucleosides as inhibitors of human mitochondrial thymidine kinase.
Balzarinia J; Degrève B; Zhu C; Durini E; Porcu L; De Clercq E; Karlsson A; Manfredini S
Biochem Pharmacol; 2001 Mar; 61(6):727-32. PubMed ID: 11266658
[TBL] [Abstract][Full Text] [Related]
27. Human deoxythymidine kinase II: substrate specificity and kinetic behavior of the cytoplasmic and mitochondrial isozymes derived from blast cells of acute myelocytic leukemia.
Lee LS; Cheng Yc
Biochemistry; 1976 Aug; 15(17):3686-90. PubMed ID: 1066165
[TBL] [Abstract][Full Text] [Related]
28. Characterization of a varicella-zoster virus variant with altered thymidine kinase activity.
Shigeta S; Mori S; Yokota T; Konno K; De Clercq E
Antimicrob Agents Chemother; 1986 Jun; 29(6):1053-8. PubMed ID: 3015014
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of N3-substituted carboranyl thymidine bioconjugates and their evaluation as substrates of recombinant human thymidine kinase 1.
Agarwal HK; McElroy CA; Sjuvarsson E; Eriksson S; Darby MV; Tjarks W
Eur J Med Chem; 2013 Feb; 60():456-68. PubMed ID: 23318906
[TBL] [Abstract][Full Text] [Related]
30. Design of species- or isozyme-specific enzyme inhibitors. 1. Effect of thymidine substituents on affinity for the thymidine site of hamster cytoplasmic thymidine kinase.
Hampton A; Kappler F; Chawla RR
J Med Chem; 1979 Jun; 22(6):621-31. PubMed ID: 458818
[TBL] [Abstract][Full Text] [Related]
31. Phosphorolysis of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and other 5-substituted-2'-deoxyuridines by purified human thymidine phosphorylase and intact blood platelets.
Desgranges C; Razaka G; Rabaud M; Bricaud H; Balzarini J; De Clercq E
Biochem Pharmacol; 1983 Dec; 32(23):3583-90. PubMed ID: 6651877
[TBL] [Abstract][Full Text] [Related]
32. Differential affinities of pyrimidine nucleoside analogues for deoxythymidine and deoxycytidine kinase determine their incorporation into murine leukemia L1210 cells.
Balzarini J; De Clercq E
Acta Biochim Pol; 1987; 34(2):63-77. PubMed ID: 2823514
[TBL] [Abstract][Full Text] [Related]
33. Regulation of thymidine kinase activity by 5-iodo-2'-deoxyuridine 5'-triphosphate and deoxythymidine 5'-triphosphate.
Prusoff WH; Chang PK
Chem Biol Interact; 1970 Feb; 1(3):285-99. PubMed ID: 5524800
[No Abstract] [Full Text] [Related]
34. Effect of thymidine and thymidylate analogs on nucleic acid synthesis in tumor cells.
Toide H; Akiyoshi H; Minato Y; Fujii S
Gan; 1977 Apr; 68(2):159-63. PubMed ID: 892290
[TBL] [Abstract][Full Text] [Related]
35. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ
Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773
[TBL] [Abstract][Full Text] [Related]
36. The mismatch repair protein, hMLH1, mediates 5-substituted halogenated thymidine analogue cytotoxicity, DNA incorporation, and radiosensitization in human colon cancer cells.
Berry SE; Garces C; Hwang HS; Kunugi K; Meyers M; Davis TW; Boothman DA; Kinsella TJ
Cancer Res; 1999 Apr; 59(8):1840-5. PubMed ID: 10213489
[TBL] [Abstract][Full Text] [Related]
37. Biochemical mechanisms in the Killmann experiment: critique of the deoxyuridine suppression test.
Pelliniemi TT; Beck WS
J Clin Invest; 1980 Feb; 65(2):449-60. PubMed ID: 6444307
[TBL] [Abstract][Full Text] [Related]
38. 5-Iodo-5'-amino-2',5'-dideoxyuridine-5'-N'-triphosphate. Synthesis, chemical properties, and effect on Escherichia coli thymidine kinase activity.
Chen MS; Ward DC; Prusoff WH
J Biol Chem; 1976 Aug; 251(16):4839-42. PubMed ID: 8448
[TBL] [Abstract][Full Text] [Related]
39. Alterations in the recognition of nucleoside analogues as substrates by the deoxythymidine kinase of a 5-methoxymethyldeoxyuridine-resistant mutant of herpes simplex virus type 1.
Veerisetty V; Veerisetty IK; Gentry GA
J Gen Virol; 1983 Dec; 64 ( Pt 12)():2767-70. PubMed ID: 6319559
[TBL] [Abstract][Full Text] [Related]
40. Potent activity of 5-fluoro-2'-deoxyuridine and related compounds against thymidine kinase-deficient (TK-) herpes simplex virus: targeted at thymidylate synthase.
De Clercq E; Bères J; Bentrude WG
Mol Pharmacol; 1987 Aug; 32(1):286-92. PubMed ID: 3039343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
